The Pegfilgrastim Biosimilars Market is transforming with trends in biologics development and manufacturing efficiency The pegfilgrastim biosimilars market consists of biosimilar drugs developed to be equivalent to Neulasta, a long-acting form of the granulocyte colony-stimulating factor filgrastim. Pegfilgrastim biosimilars help patients undergoing chemotherapy by stimulating the ... https://www.coherentmarketinsights.com/industry-reports/pegfilgrastim-biosimilars-market#:~:text=Market%20Size%20and%20Trends,9.8%25%20from%202024%20to%202031.